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ABSTRACT 
The prevalence and drug resistance of the respiratory pathogens is increasing gradually in 
Nepal. However, their detail study is rare in the western region of Nepal. Hence, this study was 
carried out to know the incidence and antibiotic susceptibility profile of the respiratory 
pathogens obtained at a tertiary care center located at Pokhara. 139 pathogens were isolated 
from 460 clinical samples included.  Significant pathogens were Gram-negative bacteria 94 
(67.62%), followed by 28 (20.15%) Candida, and Gram-positive isolates 17 (12.23%). The growth 
rate was significantly higher for sputum samples in comparison to throat swabs. Pseudomonas 
aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp were significant Gram-negative isolates 
while Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes were Gram-
positive pathogens. Sensitivity rate was higher for colistin and imipenem among Gram-negative 
isolates while lower sensitivity was for cefepime. Vancomycin was effective against all tested 
Gram-positive isolates while erythromycin and ciprofloxacin were less effective. 
Keywords: respiratory pathogens, western Nepal, Pseudomonas aeruginosa, Acinetobacter spp, 
Klebsiella pneumonia, S. aureus. 
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Introduction 
Infection of the respiratory tract is a significant 
cause of mortality as well as morbidity among the 
elderly and young people of Nepal [1]. 
Management of these infections is more complex 
in developing countries due to the lack of the 
proper identification of pathogens and their 
suitable treatment [2]. The causative agents of the 
respiratory infections are not detected in many 
cases hence physicians depend on clinical 
manifestations for the diagnosis [3]. Klebsiella 
pneumaniae, Streptococcus pneumoniae, and 
Haemophilus influenzae are the significant 
pathogens causing respiratory infections [4, 5].   
In addition to this, pathogens like Staphylococcus 
aureus, Acinetobacter, and Pseudomonas aeruginosa 
are also frequently isolated from respiratory 
specimens [6, 7].   
Polymicrobial respiratory infections by two or 
more bacteria, two or more viral pathogens, and 
mixed viral and bacterial pathogens also have 
been reported [4, 5]. Pneumonia and infection of 
lower respiratory tract are the causes of more 
than 4 million deaths per year and this problem 
is more frequent in middle-and low-income 
nations [8]. Drug resistance among these 
pathogens has been increasing as there are 
multiple reports of multidrug resistance among 
various respiratory pathogens and many of them 
are not susceptible to several routine antibiotics 
[4, 9]. Though most of the bacterial respiratory 
infections are treatable, the huge death is due to 
a lack of proper preventive measures and 
unavailability of healthcare facilities [8]. Several 
reports are indicating a gradual increase in 
antibiotic resistance among many bacterial 
pathogens responsible for respiratory diseases 
[10, 11]. 
The imprudent use of antibiotics for treating 
these infections has resulted in a very rapid 
increase in drug resistance of the respiratory 
pathogens [12]. Though various pathogens [13] 
and risk factors [14] are associated with 
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respiratory infections, their detail study is very 
limited in this region. Surveillance study on 
respiratory pathogens was imminent in this part 
of the nation. Hence this study was done to access 
the prevalence, distribution and drug resistance 
profile of the respiratory pathogens isolated at a 
tertiary care center of western Nepal. 
Materials and Methods 
Study site and duration 
The study site was Manipal Teaching Hospital, a 
750-bed multi-specialty tertiary care hospital 
located at Pokhara, Nepal. The study was 
conducted for a period of six months (July 2016 
to January 2017) at the Microbiology laboratory 
of the hospital.  
Sample collection 
Samples were collected from patients with 
clinical symptoms of respiratory tract infection as 
indicated by physicians. For the collection of 
sputum samples, patients were given various 
instructions on how to collect a sputum sample 
correctly. Clean, well-labeled, wide-necked, dry 
and leak-proof screw-cap container was 
provided to the patients for sputum collection. 
The sample was accepted only if it was sputum 
but samples containing saliva, nasal secretions, 
mucus, etc. were not analyzed. In the case of 
unacceptable samples, repeated samples were 
requested. Throat sample was collected by 
trained personals. The patient was first allowed 
to sit comfortably in a good light and using a 
tongue depressor the throat was observed for any 
swelling, redness, pus, ulcerations, exudates, and 
presence of the membrane. A sterile cotton swab 
was used to collect a sample of the infected 
throat. Special care was taken not to contaminate 
the swab with saliva and placed it into a sterile 
container.  
Macroscopic and microscopic 
examination of the sample 
Appearance, as well as presence or absence of 
blood in the given sputum, was observed and 
noted. Similarly, gram staining was performed 
from both sputum and throat swabs to observe 
pus cells and bacteria. 
Isolation and identification 
Respiratory tract samples obtained from both 
admitted and outpatients visiting the hospital 
were included in this study. Soon after collection, 
all the specimens were cultured on chocolate agar 
and 5% sheep blood agar. The inoculated plates 
were then incubated on candle jar for 18-24 
hours. Optochin and bacitracin discs were placed 
on the primary inoculation for the presumptive 
screening of S. pneumoniae and H. influenzae as 
well as S. pyogens respectively. Identification of 
the pure culture was carried out by observing 
colony characteristics and gram staining 
followed by oxidase test, catalase test, coagulase 
test, urease test, TSI test, and IMViC tests. 
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Antibiotic susceptibility test 
Kirby-Bauer disc diffusion method was used 
using Muller Hinton agar (Hi-Media, India). 
Clinical and Laboratory Standards Institute 
(CLSI) guidelines were used for the 
interpretation of the results [15]. 0.5 Mac Farland 
suspension of the isolates were used for 
inoculation. Amikacin (30µg), Azithromycin 
(15µg), Cefepime (30µg), Ceftriaxone (30µg), 
Ciprofloxacin (5µg), Colistin, (10µg) Co-
Trimoxazole (25µg), Imipenem (10µg), 
Piperacillin/ Tazobactam (100µg/10), 
Vancomycin (30µg), Levofloxacin (5µg), 
Teicoplanin (30µg), and Erythromycin (15µg) 
were used for the test. E. coli ATCC 25922 was 
used as a control organism for Gram-negative 
isolates while Staphylococcus aureus ATCC 25923 
was used as a control organism for Gram-positive 
isolates during this test.  
Results 
Among 460 samples, 139 (30.2%) showed the 
growth of respiratory pathogens. The incidence 
of the pathogens was higher from the sputum 
sample in relation to the throat sample (Table 1). 
Pseudomonas aeruginosa, Acinetobacter spp., 
Klebsiella pneumoniae, Staphylococcus aureus, 
Escherichia coli, and Candida spp. were the 
common pathogens isolated followed by 
Haemophilus influenzae, Streptococcus pneumoniae, 
Streptococcus pyogenes, and Enterobacter spp. 
Streptococcus pyogenes were isolated only from 
throat swab while all gram-negative isolates were 
only from the sputum sample. Only Candida was 
isolated from both of the samples (Table 2). 
Table 1: Total cases and types of samples 
Samples 
Growth 
positive (%) 
Growth 
negative (%) 
Total (%) 
Sputum 134 (29.13%) 299 (65%) 433 (94.13%) 
Throat 
swab 
5 (1.07%) 22 (4.8%) 27 (5.87%) 
Total 139 (30.2%) 321 (69.8%) 460 (100%) 
Vancomycin was the most effective drug for all 
three Gram-positive pathogens as all of these 
isolates were sensitive to vancomycin. 
Teicoplanin and clindamycin were also highly  
 
Table 2: Distribution of Gram-positive cocci, Gram-
negative bacilli and Candida spp. in throat swab and 
sputum samples 
Microorganisms 
Samples 
Total (%) 
Throat 
swab 
(%) 
Sputum 
(%) 
Pseudomonas 
aeruginosa 
0 31(22.3) 31 (22.3) 
Acinetobacter spp 0 26 (18.7) 26 (18.7) 
Klebsiella 
pneumoniae 
0 23 (16.55) 23 (16.55) 
Staphylococcus 
aureus 
0 9 (6.47) 9 (6.47) 
Escherichia coli 0 8 (5.76) 8 (5.76) 
Haemophilus 
influenza 
0 4 (2.88) 4 (2.88) 
Streptococcus 
pneumoniae 
0 4 (2.88) 4 (2.88) 
Streptococcus 
pyogenes 
4 (2.88) 0 4 (2.88) 
Enterobacter spp 0 2 (1.44) 2 (1.44) 
Candida spp. 1 (0.72) 27 (19.42) 28 (20.14) 
Total 5 (3.6) 134 (96.4) 139 (100) 
active against S. aureus and Streptococcus pyogenes 
respectively while other drugs were less effective 
as there was resistance ranging from 22 to 100% 
for antibiotics other than vancomycin, 
teicoplanin, and clindamycin (Table 3). Colistin 
was the most effective drug for treating 
Pseudomonas aeruginosa and Acinetobacter. Least 
drug resistance was noted on Enterobacter while 
the highest resistance was observed on 
Acinetobacter. Resistance towards all common 
antibiotics was observed in all Gram-negative 
pathogens excluding Enterobacter with varying 
percentages (Table 4). 
Discussion 
Nearly one-third of the samples were positive for 
the respiratory pathogens. Findings of the 
Shrestha et al (2005) also reported that 31% of the 
sputum samples were positive for pathogens 
[16]. Among the isolated pathogens Gram-
negative isolates were more prevalent than 
Gram-positive pathogens.  
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Table 3: Antimicrobial susceptibility profiles of Gram-positive isolates 
 
 
Antibiotics 
used 
Pathogens 
Staphylococcus aureus 
(n=9) 
Streptococcus pyogenes 
(n=4) 
Streptococcus pneumoniae 
(n=4) 
Sensitive 
No. (%) 
Resistant 
No. (%) 
Sensitive 
No. (%) 
Resistant 
No. (%) 
Sensitive No. 
(%) 
Resistant 
No. (%) 
Amikacin 7 (77.8) 2 (22.2) 3 (75) 1 (25) - - 
Ciprofloxacin 3 (33.3) 6 (66.7) - - - - 
Clindamycin 2 (22.2) 7 (77.8) 4 (100) 0 2 (50) 2 (50) 
Co-Trimoxazole - - - - 1 (25) 3 (75) 
Erythromycin 2 (22.2) 7 (77.8) 0 4 (100) 2 (50) 2 (50) 
Levofloxacin - - 0 4 (100) 3 (75) 1 (25) 
Teicoplanin 9 (100) 0 - - - - 
Vancomycin 9 (100) 0 4 (100) 0 4 (100) 0 
A very high incidence of Gram-negative 
pathogens among respiratory samples are also 
reported earlier [2, 12, 16]. Gram-negative 
isolates like Pseudomonas aeruginosa, Acinetobacter 
spp., Klebsiella pneumoniae were predominant. 
These findings were in accordance with the 
previous studies [13, 17]. Similarly, Staphylococcus 
aureus was the major Gram-positive pathogens. 
Pathogens like Streptococcus pneumoniae, 
Streptococcus pyogenes were also isolated from the 
respiratory samples. The predominance of 
Staphylococcus aureus among Gram-positive 
pathogens followed by Streptococcus spp. is 
common from respiratory samples [1, 3, 18]. 
Candida isolates were also the major cause of 
Table 4: Antimicrobial susceptibility profiles of Gram-negative bacilli 
Antibiotics 
Used 
Pathogens 
Pseudomonas 
aeruginosa 
(n=31) 
Acinetobacter 
spp 
(n=26) 
Klebsiella 
pneumoniae 
(n=23) 
E. coli 
 
(n=8) 
Haemophilus 
influenzae 
(n=4) 
Enteroba
cter 
spp 
(n=2) 
S (%) S (%) S (%) S (%) S (%) S (%) 
Amikacin 26 (83.9) 8 (30.8) 15 (65.2) 8(100) - 2 (100) 
Azithromycin - - - - 2 (50) - 
Cefepime 7 (22.6) 6 (23.1) 6 (26.1) 0 - 2 (100) 
Ceftriaxone - - - - 3 (75) - 
Ciprofloxacin 22 (71) 8 (30.8) 10 (43.5) 2 (25) 4 (100) 2 (100) 
Colistin 31 (100) 26 (100) - - - - 
Co-Trimoxazole - - 8 (34.8) 5 (62.5) 2 (50) 2 (100) 
Imipenem 23 (74.2) 9 (34.6) 21 (91.3) 7(87.5) - 2 (100) 
Piperacillin/ 
Tazobactam 
13 (42) 5 (19.2) 7 (30.4) 3 (37.5) - 2 (100) 
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respiratory infections as indicated by previous 
authors [3, 19]. 
Vancomycin was the most reliable treatment 
option for all of the gram-positive pathogens 
isolated. The high sensitivity of vancomycin 
against S. aureus and Streptococcus spp isolated 
from respiratory tract infection is found 
elsewhere [18, 19, 20]. More than 66% of S. aureus 
were resistant to Ciprofloxacin, Clindamycin, 
and Erythromycin. Increasing resistance of S. 
aureus towards these drugs is common globally 
[18, 20]. All Streptococcus pyogenes isolated in this 
study were sensitive to Clindamycin and 
Vancomycin while they were absolutely resistant 
to Levofloxacin and Erythromycin. Very similar 
antibiotic sensitivity patterns of Streptococcus 
pyogenes are reported earlier [21, 22]. The majority 
of Streptococcus pneumoniae were resistant against 
Co-Trimoxazole, Clindamycin, and 
Erythromycin. An elevated level of resistance 
among Streptococcus pneumoniae obtained from 
sputum and other samples are reported from 
different countries [23]. 
Colistin resistance was not observed in 
Pseudomonas aeruginosa and Acinetobacter spp. 
indicating that this drug is still effective as a last 
resort. There are many reports of absolute colistin 
sensitivity among gram-negative respiratory 
pathogens [24, 25]. However, there is a report of 
colistin resistance among multidrug-resistant 
Acinetobacter spp isolates obtained from ICU 
patients suffering from respiratory tract infection 
in Nepal [26]. Imipenem and amikacin resistance 
was less in gram-negative isolates in comparison 
to other antibiotics like Cefepime, Ciprofloxacin, 
Piperacillin/ Tazobactam. Less resistance is 
detected in common respiratory gram-negative 
pathogens against Imipenem and amikacin [24, 
27]. Drug resistance was higher in Acinetobacter 
spp among Gram-negative pathogens. Highly 
elevated antibiotic resistance among Acinetobacter 
isolated from respiratory tract infection is 
reported previously in Nepal [17, 26]. We also 
noticed drug resistance among Haemophilus 
influenzae as some isolates were not sensitive to 
Azithromycin, Ceftriaxone, and Co-Trimoxazole. 
Antibiotic-resistant Haemophilus influenzae 
causing respiratory tract infection is not new [2]. 
Conclusion 
Pseudomonas aeruginosa, Acinetobacter spp., 
Klebsiella pneumoniae, Candida, and S. aureus were 
the major isolates causing respiratory infection. 
Many of these isolates were resistant to various 
routine drugs. To prevent the further increase of 
antimicrobial resistance among the respiratory 
isolates antibiotic susceptibility testing must be 
done before therapy. 
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